Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Kyphomelic dysplasia is a prenatal skeletal disease that causes dwarfism characterized bythe following: a disproportionately short stature with a short narrow chest,shortening and bending (bowing)of the limbs, flared irregular metaphyses of the bones, and characteristicfacial features.Bone changes are said to improve with age.Kyphomelic dysplasia is inherited in an autosomal recessive pattern. Recent studies indicate that Kyphomelic dysplasia is no longerconsidered it's ownentity and that individual cases should be further evaluated andre-classified as another existing chondrodysplasias, such as Schwartz-Jampel syndrome.
Features include: Tibial bowing, Flared metaphysis, Micromelia, and Femoral bowing and 24 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 3 | Femoral bowing, Limitation of joint mobility, Short femur |
Head and neck |
CCN2 encodes cellular communication network factor 2 (349 aa). Major connective tissue mitoattractant secreted by vascular endothelial cells. Promotes proliferation and differentiation of chondrocytes. Highest expression in Artery Aorta (2,043 TPM) and Artery Coronary (1,105 TPM).
Kyphomelic dysplasia is associated with mutations in the CCN2 gene on chromosome 6.
The CCN2 protein participates in Trunk bipotent pancreatic progenitor cell produces pancreatic ductal cell pathway.
CCN2 is classified as a druggable target (Druggable Genome category) with score 4.0.
Genetic testing for CCN2 is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for kyphomelic dysplasia.
5 publications have been identified in PubMed for kyphomelic dysplasia. Research spans Epidemiology / Natural History (40%), Review / Meta-Analysis (20%), and Case Report / Case Series (20%).
Terayama S (2025). [PMID: 40051960](https://pubmed.ncbi.nlm.nih.gov/40051960/). *Cureus*. [Case Report / Case Series]
Singh S (2025). [PMID: 39506047](https://pubmed.ncbi.nlm.nih.gov/39506047/). *European journal of human genetics : EJHG*. [Gene Therapy / Novel Therapeutics]
Gu SL (2025). [PMID: 41121704](https://pubmed.ncbi.nlm.nih.gov/41121704/). *Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics*. [Review / Meta-Analysis]
Pattani N (2025). [PMID: 40250984](https://pubmed.ncbi.nlm.nih.gov/40250984/). *Journal of medical genetics*. [Epidemiology / Natural History]
Jacob P (2025). [PMID: 39706863](https://pubmed.ncbi.nlm.nih.gov/39706863/). *European journal of human genetics : EJHG*. [Epidemiology / Natural History]
Data assembled from 6 of 12 sources · Last updated Oct 3, 2026, 11:01 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
3
Flat face, Cleft palate, Cleft upper lip |
Muscles | 1 | Limitation of joint mobility |
Growth and development | 1 | Disproportionate short stature |
Brain and nerves | 1 | Depressed nasal bridge |